Wydanie 3/2003

Koszty leczenia retinopatii cukrzycowej w Polsce (na podstawie danych za 2002 rok)

Cost of diabetic retinopathy in Poland (based on data 2002 year)

Paweł Kawalec1, Andrzej Pilc2

1Zakład Gospodarki Lekiem, Instytut Zdrowia Publicznego
Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie
Kierownik: prof. dr hab. med. Andrzej Pilc
2Zakład Gospodarki Lekiem, Instytut Zdrowia Publicznego
Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie
Kierownik: prof. dr hab. med. Andrzej Pilc
Zakład Neurobiologii, Instytut Farmakologii Polskiej Akademii Nauk
w Krakowie
Kierownik: prof. dr hab. med. Andrzej Pilc


Summary: The aim of the analysis was to assess costs for treatment of diabetes retinopathy for Poland in 2002 from a service-provider perspective. Epidemiology data was based on current polish studies for retinopathy prevalence in Poland in recent years. Costs data for retinopathy treatment came from Cracow Clinic of Ophthalmology. Analysis was performed for direct medical costs of treatment of standard patient with diabetic retinopathy. Based on epidemiology and economical data direct medical costs of retinopathy were estimated as high as 780 million pln per year (2002). At a conclusion, these costs could be lowered by more effective screening of population for diabetes (currently only about 50% of cases in Poland is diagnosed) as well as intensive glucose level control for patients with diabetes.

Keywords: cost of illness analysis, epidemiology of retinopathy, treatment of diabetic retinopathy, direct medical costs for diabetic retinopathy


powrót

REDAKCJA NIE UDZIELA PORAD MEDYCZNYCH I NIE POŚREDNICZY W KONSULTACJACH PACJENTÓW Z LEKARZAMI